The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 levelIssam Ben Sahra, Frédéric Bost, Kathiane Laurent et al.|Oncogene|2008Cited by 852
Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1Isaam Ben Sahra, Frédéric Bost, Guillaume Robert et al.|Cancer Research|2011Cited by 620
Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer CellsIssam Ben Sahra, Frédéric Bost, Kathiane Laurent et al.|Cancer Research|2010Cited by 528
Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?Issam Ben Sahra, Frédéric Bost, Y. Le Marchand‐Brustel et al.|Molecular Cancer Therapeutics|2010Cited by 490
Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cellsYuan Yuan Wang, Catherine Muller, Camille Attané et al.|JCI Insight|2017Cited by 444